163 related articles for article (PubMed ID: 9844330)
1. Seasonal behaviour of healed duodenal ulcer.
Gupta AK; Pal LS
J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
[TBL] [Abstract][Full Text] [Related]
2. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
[TBL] [Abstract][Full Text] [Related]
3. Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
Kate V; Ananthakrishnan N; Badrinath S
Br J Surg; 2001 Aug; 88(8):1054-8. PubMed ID: 11488789
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine.
Koizumi W; Tanabe S; Imaizumi H; Kida M; Ohida M; Koshida Y; Mitomi H; Hosaka Y; Nagaba S; Sasaki T; Higuchi K; Saigenji K
Hepatogastroenterology; 2003; 50(50):577-81. PubMed ID: 12749277
[TBL] [Abstract][Full Text] [Related]
5. Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
Sou Y; Saita H; Takahashi Y; Yoshinaga T; Matsukawa Y; Sekikawa A; Nakazawa T; Shio S; Kohigashi K
J Gastroenterol; 1999; 34 Suppl 11():84-90. PubMed ID: 10616773
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
Khor CJ; Fock KM; Ng TM; Teo EK; Sim CS; Tan AL; Ng A
Singapore Med J; 2000 Aug; 41(8):382-6. PubMed ID: 11256345
[TBL] [Abstract][Full Text] [Related]
7. Seasonal relapse of healed duodenal ulcer.
Gupta AK; Pal LS
J Assoc Physicians India; 1998 May; 46(5):489. PubMed ID: 11273301
[No Abstract] [Full Text] [Related]
8. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
[TBL] [Abstract][Full Text] [Related]
9. [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori].
Amendola M; Farias R; Katz J; Luna P; Ianella M; Musi A; Boerr L; Valero J; Kogan Z; Corti R
Acta Gastroenterol Latinoam; 1999; 29(2):47-50. PubMed ID: 10491714
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
Bytzer P; Teglbjaerg PS;
Am J Gastroenterol; 2001 May; 96(5):1409-16. PubMed ID: 11374675
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer].
Di Mario F; Grasso GA; Battaglia G; De Boni M; Vianello F; De Bona M; Pasquino M; Chiozzini G; Saggioro A
Minerva Gastroenterol Dietol; 1993 Jun; 39(2):83-7. PubMed ID: 8364105
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
14. [Zantac (ranitidine) in treating duodenal ulcers].
Vasil'ev IuV
Eksp Klin Gastroenterol; 2002; (3):68-70, 121. PubMed ID: 12353395
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
Sonnenberg A; Pauly MP; Levenson SD; Schwartz JS
Am J Manag Care; 1999 Jan; 5(1):53-9. PubMed ID: 10345967
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine and antacids in the prevention of duodenal ulcer relapse in Greece.
Kalantzis N; Theodoropoulos G; Katsaros D; Tzivras M; Fertakis A; Archimandritis A
Hepatogastroenterology; 1992 Jun; 39(3):277-9. PubMed ID: 1505904
[TBL] [Abstract][Full Text] [Related]
18. Effect of sulglycotide in the prevention of duodenal ulcer relapse.
De Conca V; Saccomanno S; Dodero M; Aste H
Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):25-8. PubMed ID: 7866806
[TBL] [Abstract][Full Text] [Related]
19. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
[TBL] [Abstract][Full Text] [Related]
20. The influence of severe bulb deformity on duodenal ulcer relapse.
Piai G; Sabbatini F; Minieri M; Greco L; Sollazzo R; Mazzacca G
Hepatogastroenterology; 1990 Feb; 37(1):131-4. PubMed ID: 2312038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
